Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a caucasian mediterranean population

Metabolism: Clinical and Experimental

Volumn 46, Issue 8, 1997, Pages 976-980

  Gutierrez C ^a   Vendrell, J ^a   Pastor, R ^a   Llor, C ^a   Aguilar, C ^a   Broch, M ^a   Richart, C ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; GENE LOCATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030752421     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90090-1     Document Type: Article

References (26)

1. Andersen AR, Christiansen JS, Andersen JK, et al: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia 14:363-370, 1978
2. Parving HH, Smidt UM, Friisberg B, et al: A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20:457-461, 1981
3. Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596, 1985
4. Hall JE, Guyton AC: Control of sodium excretion and arterial pressure by intrarenal mechanisms and the renin angiotensin system, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management. New York, NY, Raven, 1990, pp 1105-1129
5. Urata H, Nishimura H, Ganten D: Chymase-dependent angiotensin II forming systems in humans. Am J Hypertens 9:277-284, 1996
6. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
7. Rigat B, Hubert C, Alhenc-Gelas F, et al: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
8. Bloem LJ, Manatunga AK, Tewksbury DA, et al: The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 93:948-953, 1995
9. Walker WG, Whelton PK, Saito H, et al: Relationship between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1:287-291, 1979
10. Watt GCM, Harrap SB, Foy CJW, et al: Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: A four corners approach to the identification of genetic determinants of blood pressure. J Hypertens 10:473-482, 1992
11. Fasola AF, Martz BL, Helmer OM: Plasma renin activity during supine exercise in offspring of hypertensive parents. J Appl Physiol 25:410-415, 1968
12. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
13. Muls E, Blaton V, Rosseneu M, et al: Serum lipids and apolipoprotein Al, A2 and B in hyperthyroidism before and after treatment. J Clin Endocrinol Metab 55:459-464, 1982
14. Lipids Research Clinics: Manual of Laboratory Operations. Lipids Research Clinics Program, vol 1. Lipid and Lipoprotein Analysis. DHEW Publication No. NIH 75-628. Washington, DC, US Government Printing Office, 1984
15. Seaquist ER, Goetz FC, Rich S, et al: Familial clustering of diabetes kidney disease. N Engl J Med 320:1161-1165, 1989
16. Marre M, Bernadet P, Gallois Y, et al: Relationships between angiotensih I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
17. Tarnow L, Cambien F, Rossing P, et al: Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 38:798-803, 1995
18. Tarnow L, Cambien F, Rossing P, et al: Lack of relationship between an insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
19. Ohno T, Kawazu S, Tomono S: Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 45:218-222, 1996
20. Tiret L, Ricard S, Porier O, et al: Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: The ECTIM Study. J Hypertens 13:311-317, 1994
21. World Health Organization Multinational Study: Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. Diabetologia 28:615-640, 1985 (suppl 1)
22. Weidmann P, Beretta-Piccoli C, Trost BN: Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 7:33-42, 1985 (suppl 2)
23. Fogarty DG, Harron JC, Hughes AE, et al: A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 45:1204-1208, 1996
24. Yoshida H, Kuriyama S, Atsumi Y, et al: Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50:657-664, 1996
25. Panagiotopoulos S, Smith TJ, Aldred GP, et al: Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes Complications 9:272-276, 1995
26. Dudley CRK, Keavney B, Stratton IM, et al: U.K. Prospective Diabetes Study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48:1907-1911, 1995